Metastron and blood albumin decreased Patient Reports March 12, 2010

Metastron Side Effects Report #5707884-5
Metastron side effect was reported by a Consumer or non-health professional from JAPAN on Apr 08, 2008. Female patient, 69 years of age, weighting 98.33 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, condition aggravated, intra-abdominal haemorrhage, protein total decreased. Metastron dosage: 3.2 ML, SINGLE DOSE. During the same period patient was treated with FENTANYL CITRATE, CLOMIPRAMINE HYDROCHLORIDE. Patient died on 03/29/2008.

Metastron Side Effects Report #5743911-7
Metastron side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2008. Female patient, 69 years of age, weighting 98.33 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, disseminated intravascular coagulation, large intestinal haemorrhage, oedema, platelet count decreased, pleural effusion, somnolence. Metastron dosage: 3.2 ML, SINGLE DOSE. During the same period patient was treated with FENTANYL, CLOMIPRAMINE HYDROCHLORIDE. Patient died on 03/29/2008.

Metastron Side Effects Report #6062304-9
Metastron side effect was reported by a Physician from JAPAN on Jan 22, 2009. Female patient, 69 years of age, weighting 98.33 lb, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, disseminated intravascular coagulation, intra-abdominal haemorrhage, oedema, pleural effusion, protein total decreased, somnolence. Metastron dosage: unknown. During the same period patient was treated with FENTANYL, CLOMIPRAMINE HYDROCHLORIDE. Patient recovered.

Metastron Side Effects Report #6016200-3
Metastron side effect was reported by a Health Professional from UNITED STATES on Dec 11, 2008. Male patient, 32 years of age, was diagnosed with metastatic pain and was treated with Metastron. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood magnesium decreased, electrocardiogram qt prolonged, humerus fracture, hypocalcaemia, inadequate analgesia, metastases to bone, myoclonus, neurotoxicity. Metastron dosage: unknown. Patient was hospitalized. Patient recovered.